Expanded Vaccination Schedule in Spain Targets Flu, HPV and Pneumococcal Disease
Spain is bolstering its public health defenses with an updated vaccination schedule set to take effect on April 1, 2026. The modern plan, approved by the Health Ministry, expands routine influenza vaccination to children up to eleven years of age and increases access to HPV vaccination for young men, alongside an update to the pneumococcal vaccine offered to older adults. These changes reflect a commitment to aligning Spanish vaccination practices with the latest scientific recommendations and adapting to evolving epidemiological conditions, aiming to protect vulnerable populations and reduce the burden of preventable diseases.
The updated Calendario de Vacunaciones e Inmunizaciones Sistemáticas (Vaccination and Immunization Schedule) builds upon recommendations from the Common Vaccination Calendar approved by the Interterritorial Council of the National Health System in December. This collaborative approach ensures a nationally coordinated response to public health challenges, incorporating both the latest vaccine availability and the current disease landscape. The changes represent a proactive step towards strengthening immunity across all age groups and minimizing the impact of seasonal and emerging infectious threats.
Protecting Children: Expanded Flu Vaccination
A key component of the revised schedule is the expansion of influenza vaccination for children. Currently, influenza vaccination is recommended for specific risk groups. However, the new schedule extends systematic vaccination with a live attenuated influenza vaccine (LAIV) administered intranasally to all children up to and including eleven years of age. This expansion is based on evidence demonstrating the benefits of childhood flu vaccination, not only in directly protecting vaccinated individuals but too in reducing transmission within communities. The Centers for Disease Control and Prevention (CDC) emphasizes the importance of annual flu vaccination for everyone six months and older.
The vaccination protocol will consist of a single dose for most children. However, children under nine years of age who are considered at higher risk and receiving their first flu vaccine will require two doses, administered four weeks apart. This tailored approach ensures optimal immune response in those most vulnerable to severe complications from influenza. The decision to expand the age range for flu vaccination reflects a growing understanding of the role childhood immunization plays in broader public health outcomes, including reducing healthcare costs and minimizing school absences.
Addressing HPV Disparities: Increased Access for Young Men
Recognizing the importance of equitable protection against the human papillomavirus (HPV), the updated schedule also focuses on increasing HPV vaccination rates among young men. The program will now actively offer HPV vaccination to unvaccinated men up to the age of 25. This builds on a previous expansion in 2025, which extended vaccination eligibility to 18-year-olds. The initiative specifically targets individuals born between 2001 and 2006. The Pan American Health Organization (PAHO) highlights the critical role of HPV vaccination in preventing infections that can lead to various cancers.
This expansion is driven by the evolving understanding of HPV’s impact on both sexes. The goal of the vaccination program is now to prevent persistent HPV infections and related diseases – including cancers of the cervix, anogenital area, and head and neck – regardless of the specific HPV genotype. Individuals identified as being at higher risk will continue to follow specific vaccination protocols as outlined in relevant health guidelines. HPV vaccination is a crucial tool in preventing a range of cancers and improving long-term health outcomes for both men and women.
Enhanced Protection Against Pneumococcal Disease
The updated schedule also includes a change in the pneumococcal vaccine offered to adults aged 65 and older. The current 20-serotype pneumococcal conjugate vaccine (VNC20) will be replaced with the newer 21-serotype vaccine (VNC21). This switch is a direct result of the availability of improved vaccines that offer broader protection against pneumococcal disease, a leading cause of serious illness and death among older adults. The transition will begin with individuals born in 1961, who will receive a single dose of the VNC21 vaccine.
adults over 65 who have not previously received a pneumococcal conjugate vaccine will also be eligible to receive the VNC21 opportunistically, with prioritization given to those born in 1951 or earlier. This ensures that a wider range of older adults benefit from the enhanced protection offered by the updated vaccine. Pneumococcal disease can manifest as pneumonia, meningitis, and bloodstream infections, making vaccination a vital preventative measure for this vulnerable population.
All vaccines included in the updated schedule will remain free of charge for eligible individuals. While vaccination is a voluntary act, health authorities strongly recommend it as one of the most effective public health interventions for preventing disease and saving lives. The Directorate General of Public Health is responsible for vaccine procurement and distribution, and detailed technical instructions for administration will be published on the Health Portal of the Regional Ministry of Health (www.saludcastillayleon.es).
Key Takeaways
- Expanded Flu Protection: Routine influenza vaccination is now recommended for all children up to 11 years old.
- HPV Vaccination for Young Men: Increased access to HPV vaccination for men up to 25 years of age aims to address gender disparities in protection.
- Updated Pneumococcal Vaccine: A new 21-serotype pneumococcal vaccine will replace the current 20-serotype vaccine for adults 65 and older.
- Free and Voluntary: All vaccines included in the updated schedule remain free of charge and are offered on a voluntary basis.
The implementation of this revised vaccination schedule represents a significant investment in public health in Spain. By expanding access to vital vaccines and updating existing protocols, authorities are working to protect communities from preventable diseases and improve the overall health and well-being of the population. Further updates and detailed guidance will be available on the Regional Ministry of Health’s website in the coming weeks.
The next key date to watch is April 1, 2026, when the updated vaccination schedule officially comes into effect. Readers are encouraged to consult with their healthcare providers to determine the best vaccination plan for themselves and their families. Share your thoughts and questions in the comments below.